日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immunotherapy targeting drug-tolerant Mycobacterium tuberculosis persisters accelerates tuberculosis cure in preclinical models.

针对耐药结核分枝杆菌持续感染者的免疫疗法可加速临床前模型中结核病的治愈。

Karanika Styliani, Wang Tianyin, Yilma Addis, Ruelas Castillo Jennie, Gordy James T, Bailey Hannah, Quijada Darla, Fessler Kaitlyn, Tasneen Rokeya, Rouse Salcido Elisa M, Shamma Farah, Harris Harley T, Chen Fengyixin, Bates Rowan E, Ton Heemee, Meza Jacob, Li Yangchen, Taylor Alannah D, Zheng Jean J, Zhang Jiaqi, Karantanos Theodoros, Maxwell Amanda R, Nuermberger Eric, Peske J David, Markham Richard B, Karakousis Petros C

Novel Vaccines Targeting the Highly Conserved SARS-CoV-2 ORF3a Ectodomain Elicit Immunogenicity in Mouse Models.

针对高度保守的 SARS-CoV-2 ORF3a 胞外结构域的新型疫苗在小鼠模型中诱导免疫原性

Meza Jacob, Glass Elizabeth, Sandhu Avinaash K, Li Yangchen, Karanika Styliani, Fessler Kaitlyn, Hui Yinan, Schill Courtney, Wang Tianyin, Zhang Jiaqi, Bates Rowan E, Taylor Alannah D, Kapoor Aakanksha R, Ayeh Samuel K, Karakousis Petros C, Markham Richard B, Gordy James T